清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Expansion, differentiation, and culture of hematopoietic stem & progenitor cells using an ancillary GMP-compliant medium

祖细胞 造血 脐带血 干细胞 细胞生物学 细胞疗法 生物 川地34 免疫学 诱导多能干细胞 细胞培养 免疫系统 原电池 细胞分化 离体 细胞 骨髓 移植 成体干细胞 再生医学 白细胞介素3 化学定义介质
作者
Tim Le Fevre,Elaine Ang,Mónica Romera Hernández,Crystal Chau,Brandon Wong,Iulia Oros,Diana Golubeva,Jessica Hitchon,Marta Walasek,Andy Kokaji,Allen Eaves,Sharon Louis,Nooshin Tabatabaei-Zavareh
出处
期刊:Blood [Elsevier BV]
卷期号:146 (Supplement 1): 2402-2402
标识
DOI:10.1182/blood-2025-2402
摘要

Abstract Hematopoietic stem and/or progenitor cells (HSPCs) from human primary or pluripotent stem cells (hPSCs) and their derivatives, natural killer (NK), B, and T cells, hold promise as effective cellular therapies to treat various diseases, including malignancies. A significant challenge in manufacturing HSPC-derived cellular therapies is culturing sufficient numbers of HSPCs while preserving their potency and self-renewal. Concurrently, ex vivo differentiation of HSPCs into immune cells offers a cost-effective, allogeneic source for immune cell therapy. However, this entire process relies on reliable cell culture reagents that can support the expansion of functional HSPCs, as well as their subsequent differentiation into various blood cells, including T and NK cells. For clinical-grade cell and gene therapy products, high-quality ancillary materials compliant with current good manufacturing practice (cGMP) regulations are a requirement. We developed a cGMP-compliant culture medium designed to support the maintenance, expansion, and differentiation of HSPCs from both human primary and hPSC-derived progenitors. This novel HSPC medium is serum- and phenol red-free, and specifically designed to support further cell therapy manufacturing of HSPCs and HSPC-derived T and NK cells. To evaluate the novel HSPC medium, CD34+ HSPCs were isolated immunomagnetically from cord blood (CB) and cultured in HSPC medium supplemented with StemSpan™ CD34+ Expansion Supplement containing Flt3L, SCF, TPO, IL-3, and IL-6 plus 1 μM UM729 for 7 days. Expanded CB-derived CD34+ cells showed an average fold expansion of 117 ± 21 cells per input HSPC, with 53 ± 5% retaining CD34 expression (n = 6; mean ± SEM) after 7 days of culture. Notably, 6 ± 1% of the cells were also CD34+CD45RA-CD90+EPCR+, a phenotype indicative of a hematopoietic stem cell-enriched population. The yield of CD34+CD45RA-CD90+EPCR+ cells was 8 ± 2 per input cell. T and NK Differentiation potential was assessed by using HSPC medium supplemented with commercially available reagents. For differentiation to CD4+CD8+ double-positive (DP) T cells, CB- and hPSC-derived CD34+ HSPCs were differentiated for 42 and 28 days, respectively. CB-derived cultures displayed an average frequency of 20 ± 8% CD4+CD8+ cells with a yield of 21,300 ± 16,800 cells per input CD34+ HSPC (n = 6), while hPSC-derived cultures generated 34 ± 14% to CD4+CD8+ cells with a yield of 31 ± 7 cells per input CD34+ cell (n = 3; mean ± SEM). Notably, 10 ± 2% of the CB-derived and 23 ± 8% of the hPSC-derived CD4+CD8+ DP T cells also expressed CD3 and TCRαß, indicating a more differentiated phenotype. DP T cells from both cell sources were able to differentiate to more mature CD8 single-positive T cells. For differentiation to CD56+ NK cells, CB- and hPSC-derived CD34+ HSPCs were differentiated for 28 and 21 days, respectively. CB-derived cultures displayed an average frequency of 89 ± 1% CD56+ cells with a yield of 20,300 ± 3,700 cells per input CD34+ HSPC (n = 6; mean ± SEM ), while hPSC-derived cultures generated 84 ± 3% to CD56+ cells with a yield of 464 ± 132 cells per input CD34+ cell (n = 13; mean ± SEM). These results highlight the utility of this HSPC medium to generate high yields of T and NK cells required for large-scale cell manufacturing. Taken together, our data show that this novel cGMP-compliant HSPC medium enables efficient cord blood- and hPSC-derived HSPC expansion and differentiation to T and NK cells—both of which are crucial to meet the demands of immunotherapy research. These results demonstrate its potential to facilitate the development of cell and gene therapies, where their successful clinical manufacturing relies on robust and scalable cell expansion and differentiation protocols.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
名字有点甜诶完成签到 ,获得积分10
1秒前
1秒前
年轻新晴完成签到,获得积分10
2秒前
2秒前
7秒前
Jannatul发布了新的文献求助10
8秒前
Research完成签到 ,获得积分10
11秒前
12秒前
龙弟弟完成签到 ,获得积分10
17秒前
22秒前
体贴的小霜完成签到,获得积分10
22秒前
魔幻雅柔完成签到,获得积分10
28秒前
Zephyr完成签到 ,获得积分10
29秒前
31秒前
清新的方盒完成签到 ,获得积分10
33秒前
36秒前
Jannatul完成签到,获得积分10
38秒前
41秒前
pericles发布了新的文献求助10
42秒前
51秒前
1分钟前
1分钟前
ubless607的应助被科研通管家采纳,获得10
1分钟前
怕黑的驳完成签到,获得积分10
1分钟前
老猫322完成签到 ,获得积分10
1分钟前
1分钟前
英俊的傲珊完成签到,获得积分10
1分钟前
1分钟前
小橙子完成签到 ,获得积分10
1分钟前
qaplay完成签到 ,获得积分0
1分钟前
1分钟前
白嫖论文完成签到 ,获得积分10
1分钟前
1分钟前
CHME完成签到 ,获得积分10
1分钟前
Z小姐完成签到 ,获得积分10
1分钟前
jiayouliyi完成签到 ,获得积分10
1分钟前
1分钟前
玛卡巴卡爱吃饭完成签到 ,获得积分0
2分钟前
2分钟前
炙热迎天完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185496
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783092
什么是DOI,文献DOI怎么找? 3434577
关于科研通互助平台的介绍 2558949
邀请新用户注册赠送积分活动 2481346